GlassScriptPhysician profile
Stephen A Brassell
NPI 1538108311
$2,591.73
in general payments reported to CMS, 2019-2025
11 companies · $297 in 2025
The $297 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $137 · 2021: $42.40 · 2022: $279 · 2023: $330 · 2024: $1,355 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,982.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $1,128.12 | 2022-2024 | |
| Intuitive Surgical, INC. | $620.35 | 2019-2024 | Da Vinci Surgical System |
| Urogen Pharma, INC. | $281.63 | 2024-2025 | |
| Janssen Biotech, INC. | $198.47 | 2020-2025 | Balversa, Erleada |
| Ferring Pharmaceuticals INC. | $131.18 | 2024 | Adstiladrin |
| Bayer Healthcare Pharmaceuticals INC. | $128.99 | 2023 | |
| Procept Biorobotics Corporation | $45.29 | 2025 | |
| Stimwave Technologies Incorporated | $38.58 | 2021 | |
| Olympus America INC. | $15.30 | 2019 | |
| Travere Therapeutics, INC. | $3.82 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Brassell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.